Why retina PPC is a different conversation

Most retina groups get 80%+ of new patients through referrals from ODs and general ophthalmologists. Retina PPC is one of the most contested ROI decisions in eye care, contested because nobody has published the numbers. Most discussions are anecdotal, agency-driven, or extrapolated from cataract benchmarks that do not apply.

The argument is not “do not spend” or “spend more,” it is “spend on the narrow segments where PPC moves the needle and avoid broad bidding against established tertiary centers.” Most retina groups should run a small, targeted program, not a large brand-awareness program mimicking cataract or LASIK strategy.

PE consolidation shapes the question further. Retina has been heavily consolidated, with regional groups rolling into multi-state platforms over five years. The shift moved the question from “how does this practice get patients” to “how does this platform allocate budget across locations with different referral-network maturity.” The PPC question persists because platform marketing leadership often comes from outside healthcare and brings consumer-PPC instincts to a specialty where consumer PPC is not the lever. The honest answer requires committing to a segment-by-segment framework that fits how retina patients actually arrive.

How retina patients actually find specialists

Retina conditions (diabetic retinopathy, AMD, retinal detachment, vein occlusion) are diagnosed upstream. The OD sees retinal hemorrhages on dilated exam, the PCP notices vision complaints in a diabetic patient, the general ophthalmologist identifies wet AMD on imaging. The patient does not self-diagnose retinal pathology; they are sent.

Direct-to-consumer search is thin compared to surgical specialties. Patients searching “retina specialist [city]” exist but are typically already referred. The PPC question is not “should retina groups rank for retina specialist,” that traffic is mostly branded, but “which narrow segments justify dedicated PPC spend producing incremental new patients.”

The narrow segments exist. Emergency symptom searchers (“floaters and flashes,” “sudden vision loss,” “curtain over vision”) arrive without referral when symptoms are acute. Second-opinion seekers, recently-diagnosed patients, and clinical-trial recruits generate addressable intent. Each is small. Retina PPC strategy is precision targeting, not broad coverage.

Upstream diagnosis pathways make the structure clearer. A diabetic patient sees their OD for annual exam, microaneurysms are identified, and the patient is referred. An ER physician evaluates a sudden vision curtain, suspects detachment, and refers urgently. A general ophthalmologist managing wet AMD refers for anti-VEGF management. In each pathway, the patient never searches Google for a retina specialist. The narrow direct-to-consumer segments (acute symptom research, second-opinion shopping, trial discovery) sit on top of an overwhelmingly referral-driven base, and strategy must reflect that ratio.

Benchmarks and reference points

No public retina-specific CPC data was located in sources reviewed. Directional context: retina falls under Ophthalmology category-level CVR of 18.29% (LocaliQ 2025). Specialty-service tCPA anchors run $85-$125 per booked consult (Ryze, April 2026), likely higher for retina given the small addressable audience and competition from large tertiary centers in major metros.

Referral network share of new patients typically runs 70-90% for retina practices. Healthcare CPC averages $5.64 (LocaliQ 2025) but retina-specific terms can run materially higher in competitive metros. Budget posture matters more than absolute spend, the right $5K/month often outperforms the wrong $25K/month. Pair with disciplined eye care PPC benchmarks review to avoid copying surgical-procedure budget posture into a retina account.

The Specialty-service tCPA range of $85-$125 from Ryze (April 2026) gives a working anchor, but retina likely runs above the upper end for two reasons. Addressable search volume is smaller than for cataract or LASIK, producing less impression density and higher CPCs. The per-conversion value is also higher because retina patients often enter long-term injection or surveillance programs, so the practice can justify a higher acquisition cost when the math is run on full lifetime value rather than first-visit revenue. The referral-network economics are the appropriate baseline for any PPC ROI conversation. If the practice acquires referred patients at effectively zero direct marketing cost through OD relationships, any PPC spend must clear the referral baseline before it adds incremental value, not match the direct CPL of cataract or LASIK programs that operate in different demand structures.

When PPC makes sense for retina

Several specific contexts justify retina PPC spend. First, urgent or emergency symptom searches (“floaters and flashes,” “sudden vision loss,” “curtain over vision,” “wavy lines vision”) in markets with weak competition or where the practice has same-day appointment capacity. These searchers convert when ads route them to a clear urgent-care booking path.

Second, second-opinion intent, patients recently diagnosed with wet AMD or diabetic retinopathy who are researching whether their treatment plan is appropriate. Third, newly-diagnosed patient research on specific conditions (anti-VEGF treatment, vitrectomy recovery, retinal detachment surgery). Fourth, MIGS or surgical pathway overlap with glaucoma where the patient may need both retinal and glaucoma evaluation. Fifth, recruiting for clinical trials, retina is one of the most active trial specialties in eye care, and PPC can efficiently fill enrollment slots. Pair with solid Google Ads management practices to keep these targeted campaigns from drifting.

Sixth, recruiting for clinical trials at academic-affiliated retina practices, where IRB-approved trial protocols often have specific demographic and condition-stage criteria that PPC can target with precision. Trial enrollment slots are time-sensitive, and PPC can fill an enrollment shortfall in weeks where SEO would take months. Seventh, HCP-targeted B2B campaigns to referring ODs after the July 2025 policy reopening, which overlaps directly with the glaucoma B2B playbook. Retina practices share the same referral-network economics as glaucoma, and the same Customer Match list of referring ODs can support B2B remarketing for both sub-specialties when the practice runs both.

When PPC does not make sense for retina

Several patterns indicate retina PPC budget is being wasted. First, generic “retina specialist [city]” broad bidding, the referral networks decide which practice gets the appointment, not the ad rank. Second, condition-page remarketing, which combines HIPAA risk with low downstream yield because the audience is already in active treatment elsewhere.

Third, competing against established tertiary centers in major metros where the brand recognition gap cannot be closed by ad spend. Fourth, expecting PPC to replace referral relationships, the OD and PCP networks generate the patient flow, and PPC is supplementary at best. Fifth, optimizing campaigns to form fills that turn out to be information-seekers (patients researching their family member’s diagnosis, students, attorneys investigating cases) rather than actual prospective patients. Audit lead quality through the lead quality blind spot framework and watch for agency red flags that suggest budget is being deployed without segment discipline.

Sixth, competing against NIH-funded clinical trial recruitment in the same condition area, where the trial sponsor can outbid private-practice CPLs effectively indefinitely because the recruitment budget is institutional rather than ROI-constrained. Competing with an active NIH trial recruitment campaign in the same geography and condition loses the auction every time. Seventh, optimizing for “ophthalmologist near me” generic queries that are not retina-specific, which produces high click volume but low conversion to retina-appropriate consults because the searcher intent does not match the practice’s sub-specialty offering. Pull these queries out as exact-match negatives at the campaign level rather than letting them absorb impression share.

Specialty Vision’s Take on Retina PPC

Our view: most retina groups should spend 60-80% of patient acquisition effort on referral-partner relationships, 15-25% on SEO and content for symptom-stage searchers, and 5-15% on tightly-scoped PPC. Generic PPC spend over 20% of marketing budget is almost always the wrong allocation for retina. We help retina practices size the program correctly. The right cadence for revisiting that allocation is annual, with a sub-quarterly check on the PPC line if the practice has launched new locations or new clinical-trial recruitment. The rare cases where PPC justifies a higher allocation are urgent-symptom-dominant markets with weak retina competition, typically secondary metros where the closest tertiary center is 90+ minutes away and the practice can credibly market same-day urgent appointments to acute symptom searchers. In those markets, PPC for emergency intent can run at 20-30% of marketing budget and still produce sound ROI. Outside those conditions, we hold the line on the 5-15% range and redirect budget toward referral relationships and content. See our 2026 PPC audit playbook for the full diagnostic framework.